Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells.

Carsten PelzSonja HäckelGeo SeminiSandra SchrötterWillem BintigSebastian StrickerGudrun MrawietzAndreas KleinLothar LuckaVadim ShmanaiBritta EickholtAnnette HildmannKerstin Danker

Published in: Cellular oncology (Dordrecht) (2018)

The antagonistic effects of Inositol-C2-PAF on cell migration and proliferation are indicative for its potential for breast cancer therapy, alone or in combination with other cytostatic drugs.

Keyphrases

cell migration
cancer therapy
papillary thyroid
drug delivery
signaling pathway
squamous cell
lymph node metastasis
squamous cell carcinoma
childhood cancer
young adults
drug induced